Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Small Cell Lung Carcinoma 46Lymphoma, Large B-Cell, Diffuse 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Lung Neoplasms 21Leukemia, Myeloid, Acute 20Burkitt Lymphoma 18Hodgkin Disease 15Recurrence 14Lymphoma, Non-Hodgkin 14Lymphoma 14Carcinoma, Non-Small-Cell Lung 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Neuroblastoma 10Lymphoma, Mantle-Cell 10Lymphoma, B-Cell 10Leukemia 10Medulloblastoma 8Neoplasms, Germ Cell and Embryonal 7Neoplasms 7Lymphoma, Follicular 7Multiple Myeloma 6Lymphoma, T-Cell 6Brain Neoplasms 6Sarcoma, Ewing 5Retinoblastoma 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Immunoblastic Lymphadenopathy 5Ependymoma 5Sarcoma 4Rhabdomyosarcoma 4

Interventions

fludarabine phosphate 2Cyclophosphamide 2pevonedistat 1ibrutinib 1Specimen Handling 1Pharmacogenomic Variants 1Leukapheresis 1Etoposide 1Blood Component Removal 1Biopsy 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Prolymphocytic, B-Cell × Etoposide × 1 year × Clear all
NCT02153580 2025-10-06

Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia

City of Hope Medical Center

Phase 1 Active not recruiting
37 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Hairy Cell, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Prolymphocytic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡